Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03984240Completed
Open-label trial of midazolam and dexmedetomidine in brain glioma (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Brain network connectivity at 2 hours. Started Nov 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03984240.